Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury.

Bradley-Whitman MA, Roberts KN, Abner EL, Scheff SW, Lynn BC, Lovell MA.

Brain Inj. 2018;32(3):363-380. doi: 10.1080/02699052.2017.1418907. Epub 2017 Dec 28.

PMID:
29283288
2.

Natural Compounds as a Therapeutic Intervention following Traumatic Brain Injury: The Role of Phytochemicals.

Scheff SW, Ansari MA.

J Neurotrauma. 2017 Apr 15;34(8):1491-1510. doi: 10.1089/neu.2016.4718. Epub 2016 Dec 21. Review.

PMID:
27846772
3.

Cognitive assessment of pycnogenol therapy following traumatic brain injury.

Scheff SW, Roberts KN.

Neurosci Lett. 2016 Nov 10;634:126-131. doi: 10.1016/j.neulet.2016.10.016. Epub 2016 Oct 11.

4.

Molecular and cellular pathophysiology of preclinical Alzheimer's disease.

Mufson EJ, Ikonomovic MD, Counts SE, Perez SE, Malek-Ahmadi M, Scheff SW, Ginsberg SD.

Behav Brain Res. 2016 Sep 15;311:54-69. doi: 10.1016/j.bbr.2016.05.030. Epub 2016 May 13. Review.

5.

Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology.

Scheff SW, Ansari MA, Mufson EJ.

Neurobiol Aging. 2016 Jun;42:1-12. doi: 10.1016/j.neurobiolaging.2016.02.030. Epub 2016 Mar 8.

6.

Blockade of Astrocytic Calcineurin/NFAT Signaling Helps to Normalize Hippocampal Synaptic Function and Plasticity in a Rat Model of Traumatic Brain Injury.

Furman JL, Sompol P, Kraner SD, Pleiss MM, Putman EJ, Dunkerson J, Mohmmad Abdul H, Roberts KN, Scheff SW, Norris CM.

J Neurosci. 2016 Feb 3;36(5):1502-15. doi: 10.1523/JNEUROSCI.1930-15.2016.

7.

Pycnogenol protects CA3-CA1 synaptic function in a rat model of traumatic brain injury.

Norris CM, Sompol P, Roberts KN, Ansari M, Scheff SW.

Exp Neurol. 2016 Feb;276:5-12. doi: 10.1016/j.expneurol.2015.11.006. Epub 2015 Nov 29.

8.

Hippocampal plasticity during the progression of Alzheimer's disease.

Mufson EJ, Mahady L, Waters D, Counts SE, Perez SE, DeKosky ST, Ginsberg SD, Ikonomovic MD, Scheff SW, Binder LI.

Neuroscience. 2015 Nov 19;309:51-67. doi: 10.1016/j.neuroscience.2015.03.006. Epub 2015 Mar 12. Review.

9.

A time course of NADPH-oxidase up-regulation and endothelial nitric oxide synthase activation in the hippocampus following neurotrauma.

Ansari MA, Roberts KN, Scheff SW.

Free Radic Biol Med. 2014 Dec;77:21-9. doi: 10.1016/j.freeradbiomed.2014.08.025. Epub 2014 Sep 16.

10.

Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease.

Scheff SW, Price DA, Ansari MA, Roberts KN, Schmitt FA, Ikonomovic MD, Mufson EJ.

J Alzheimers Dis. 2015;43(3):1073-90. doi: 10.3233/JAD-141518.

11.

Development of a database for translational spinal cord injury research.

Nielson JL, Guandique CF, Liu AW, Burke DA, Lash AT, Moseanko R, Hawbecker S, Strand SC, Zdunowski S, Irvine KA, Brock JH, Nout-Lomas YS, Gensel JC, Anderson KD, Segal MR, Rosenzweig ES, Magnuson DS, Whittemore SR, McTigue DM, Popovich PG, Rabchevsky AG, Scheff SW, Steward O, Courtine G, Edgerton VR, Tuszynski MH, Beattie MS, Bresnahan JC, Ferguson AR.

J Neurotrauma. 2014 Nov 1;31(21):1789-99. doi: 10.1089/neu.2014.3399. Epub 2014 Jul 31.

12.

Evidence for Alzheimer's disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons.

Neuman KM, Molina-Campos E, Musial TF, Price AL, Oh KJ, Wolke ML, Buss EW, Scheff SW, Mufson EJ, Nicholson DA.

Brain Struct Funct. 2015 Nov;220(6):3143-65. doi: 10.1007/s00429-014-0848-z. Epub 2014 Jul 17.

13.

A distinct subfraction of Aβ is responsible for the high-affinity Pittsburgh compound B-binding site in Alzheimer's disease brain.

Matveev SV, Spielmann HP, Metts BM, Chen J, Onono F, Zhu H, Scheff SW, Walker LC, LeVine H 3rd.

J Neurochem. 2014 Nov;131(3):356-68. doi: 10.1111/jnc.12815. Epub 2014 Jul 28.

14.

White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults.

Gold BT, Zhu Z, Brown CA, Andersen AH, LaDu MJ, Tai L, Jicha GA, Kryscio RJ, Estus S, Nelson PT, Scheff SW, Abner E, Schmitt FA, Van Eldik LJ, Smith CD.

Neurobiol Aging. 2014 Oct;35(10):2263-71. doi: 10.1016/j.neurobiolaging.2014.04.030. Epub 2014 May 2.

15.

ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.

Nelson PT, Estus S, Abner EL, Parikh I, Malik M, Neltner JH, Ighodaro E, Wang WX, Wilfred BR, Wang LS, Kukull WA, Nandakumar K, Farman ML, Poon WW, Corrada MM, Kawas CH, Cribbs DH, Bennett DA, Schneider JA, Larson EB, Crane PK, Valladares O, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Scheff SW, Sonnen JA, Haines JL, Pericak-Vance MA, Mayeux R, Farrer LA, Van Eldik LJ, Horbinski C, Green RC, Gearing M, Poon LW, Kramer PL, Woltjer RL, Montine TJ, Partch AB, Rajic AJ, Richmire K, Monsell SE; Alzheimer’ Disease Genetic Consortium, Schellenberg GD, Fardo DW.

Acta Neuropathol. 2014;127(6):825-43. doi: 10.1007/s00401-014-1282-2. Epub 2014 Apr 27.

16.

Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease.

Perez SE, He B, Nadeem M, Wuu J, Scheff SW, Abrahamson EE, Ikonomovic MD, Mufson EJ.

Biol Psychiatry. 2015 Apr 15;77(8):693-703. doi: 10.1016/j.biopsych.2013.12.016. Epub 2014 Jan 11.

17.

Is synaptic loss a unique hallmark of Alzheimer's disease?

Scheff SW, Neltner JH, Nelson PT.

Biochem Pharmacol. 2014 Apr 15;88(4):517-28. doi: 10.1016/j.bcp.2013.12.028. Epub 2014 Jan 9. Review.

18.

Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease.

Nelson PT, Smith CD, Abner EL, Wilfred BJ, Wang WX, Neltner JH, Baker M, Fardo DW, Kryscio RJ, Scheff SW, Jicha GA, Jellinger KA, Van Eldik LJ, Schmitt FA.

Acta Neuropathol. 2013 Aug;126(2):161-77. doi: 10.1007/s00401-013-1154-1. Epub 2013 Jul 18. Review.

19.

Dose- and time-dependent neuroprotective effects of Pycnogenol following traumatic brain injury.

Ansari MA, Roberts KN, Scheff SW.

J Neurotrauma. 2013 Sep 1;30(17):1542-9. doi: 10.1089/neu.2013.2910. Epub 2013 Jul 17.

20.

Synapse stability in the precuneus early in the progression of Alzheimer's disease.

Scheff SW, Price DA, Schmitt FA, Roberts KN, Ikonomovic MD, Mufson EJ.

J Alzheimers Dis. 2013;35(3):599-609. doi: 10.3233/JAD-122353.

21.

Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease.

Mufson EJ, He B, Nadeem M, Perez SE, Counts SE, Leurgans S, Fritz J, Lah J, Ginsberg SD, Wuu J, Scheff SW.

J Neuropathol Exp Neurol. 2012 Nov;71(11):1018-29. doi: 10.1097/NEN.0b013e318272caab.

22.

Neuroprotective effect of Pycnogenol® following traumatic brain injury.

Scheff SW, Ansari MA, Roberts KN.

Exp Neurol. 2013 Jan;239:183-91. doi: 10.1016/j.expneurol.2012.09.019. Epub 2012 Oct 8.

23.

Inhibition of soluble tumor necrosis factor ameliorates synaptic alterations and Ca2+ dysregulation in aged rats.

Sama DM, Mohmmad Abdul H, Furman JL, Artiushin IA, Szymkowski DE, Scheff SW, Norris CM.

PLoS One. 2012;7(5):e38170. doi: 10.1371/journal.pone.0038170. Epub 2012 May 29.

24.

Lateralized response of dynorphin a peptide levels after traumatic brain injury.

Hussain ZM, Fitting S, Watanabe H, Usynin I, Yakovleva T, Knapp PE, Scheff SW, Hauser KF, Bakalkin G.

J Neurotrauma. 2012 Jun 10;29(9):1785-93. doi: 10.1089/neu.2011.2286. Epub 2012 May 21.

25.

Hippocampal drebrin loss in mild cognitive impairment.

Counts SE, He B, Nadeem M, Wuu J, Scheff SW, Mufson EJ.

Neurodegener Dis. 2012;10(1-4):216-9. doi: 10.1159/000333122. Epub 2012 Feb 4.

26.

Mild cognitive impairment: pathology and mechanisms.

Mufson EJ, Binder L, Counts SE, DeKosky ST, de Toledo-Morrell L, Ginsberg SD, Ikonomovic MD, Perez SE, Scheff SW.

Acta Neuropathol. 2012 Jan;123(1):13-30. doi: 10.1007/s00401-011-0884-1. Epub 2011 Nov 19. Review.

27.

Posttraumatic mossy fiber sprouting is related to the degree of cortical damage in three mouse strains.

Hunt RF, Haselhorst LA, Schoch KM, Bach EC, Rios-Pilier J, Scheff SW, Saatman KE, Smith BN.

Epilepsy Res. 2012 Mar;99(1-2):167-70. doi: 10.1016/j.eplepsyres.2011.10.011. Epub 2011 Nov 1.

28.

Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease.

Ikonomovic MD, Klunk WE, Abrahamson EE, Wuu J, Mathis CA, Scheff SW, Mufson EJ, DeKosky ST.

Neurology. 2011 Jul 5;77(1):39-47. doi: 10.1212/WNL.0b013e3182231419. Epub 2011 Jun 22.

29.

Unaltered prion protein expression in Alzheimer disease patients.

Saijo E, Scheff SW, Telling GC.

Prion. 2011 Apr-Jun;5(2):109-16. Epub 2011 Apr 1.

30.

Synaptic reorganization of inhibitory hilar interneuron circuitry after traumatic brain injury in mice.

Hunt RF, Scheff SW, Smith BN.

J Neurosci. 2011 May 4;31(18):6880-90. doi: 10.1523/JNEUROSCI.0032-11.2011.

31.

Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.

Nelson PT, Head E, Schmitt FA, Davis PR, Neltner JH, Jicha GA, Abner EL, Smith CD, Van Eldik LJ, Kryscio RJ, Scheff SW.

Acta Neuropathol. 2011 May;121(5):571-87. doi: 10.1007/s00401-011-0826-y. Epub 2011 Apr 24. Review.

32.

NADPH-oxidase activation and cognition in Alzheimer disease progression.

Ansari MA, Scheff SW.

Free Radic Biol Med. 2011 Jul 1;51(1):171-8. doi: 10.1016/j.freeradbiomed.2011.03.025. Epub 2011 Mar 30.

33.

Rate of neurodegeneration in the mouse controlled cortical impact model is influenced by impactor tip shape: implications for mechanistic and therapeutic studies.

Pleasant JM, Carlson SW, Mao H, Scheff SW, Yang KH, Saatman KE.

J Neurotrauma. 2011 Nov;28(11):2245-62. doi: 10.1089/neu.2010.1499. Epub 2011 Apr 21.

34.

Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease.

Scheff SW, Price DA, Schmitt FA, Scheff MA, Mufson EJ.

J Alzheimers Dis. 2011;24(3):547-57. doi: 10.3233/JAD-2011-101782.

35.

Melatonin and minocycline for combinatorial therapy to improve functional and histopathological deficits following traumatic brain injury.

Kelso ML, Scheff NN, Scheff SW, Pauly JR.

Neurosci Lett. 2011 Jan 13;488(1):60-4. doi: 10.1016/j.neulet.2010.11.003. Epub 2010 Nov 5.

36.

William R. Markesbery, M.D.: mentor and friend.

Scheff SW.

Neuromolecular Med. 2011 Mar;13(1):3-5. doi: 10.1007/s12017-010-8118-6. Epub 2010 Jun 11. No abstract available.

PMID:
20544306
37.

Age-related mitochondrial changes after traumatic brain injury.

Gilmer LK, Ansari MA, Roberts KN, Scheff SW.

J Neurotrauma. 2010 May;27(5):939-50. doi: 10.1089/neu.2009.1181.

38.

Regionally localized recurrent excitation in the dentate gyrus of a cortical contusion model of posttraumatic epilepsy.

Hunt RF, Scheff SW, Smith BN.

J Neurophysiol. 2010 Mar;103(3):1490-500. doi: 10.1152/jn.00957.2009. Epub 2010 Jan 20.

39.

Oxidative stress in the progression of Alzheimer disease in the frontal cortex.

Ansari MA, Scheff SW.

J Neuropathol Exp Neurol. 2010 Feb;69(2):155-67. doi: 10.1097/NEN.0b013e3181cb5af4.

40.

Age-related changes in mitochondrial respiration and oxidative damage in the cerebral cortex of the Fischer 344 rat.

Gilmer LK, Ansari MA, Roberts KN, Scheff SW.

Mech Ageing Dev. 2010 Feb;131(2):133-43. doi: 10.1016/j.mad.2009.12.011. Epub 2010 Jan 18.

41.
42.

Early mitochondrial dysfunction after cortical contusion injury.

Gilmer LK, Roberts KN, Joy K, Sullivan PG, Scheff SW.

J Neurotrauma. 2009 Aug;26(8):1271-80. doi: 10.1089/neu.2008.0857.

43.

Recovery of afferent function and synaptic strength in hippocampal CA1 following traumatic brain injury.

Norris CM, Scheff SW.

J Neurotrauma. 2009 Dec;26(12):2269-78. doi: 10.1089/neu.2009.1029.

44.

Posttraumatic epilepsy after controlled cortical impact injury in mice.

Hunt RF, Scheff SW, Smith BN.

Exp Neurol. 2009 Feb;215(2):243-52. doi: 10.1016/j.expneurol.2008.10.005. Epub 2008 Oct 26.

45.

Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment.

Nelson PT, Abner EL, Scheff SW, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Patel E, Markesbery WR.

Neurosci Lett. 2009 Feb 6;450(3):336-9. doi: 10.1016/j.neulet.2008.11.006. Epub 2008 Nov 8.

46.

Protective effect of Pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicity.

Ansari MA, Keller JN, Scheff SW.

Free Radic Biol Med. 2008 Dec 1;45(11):1510-9. doi: 10.1016/j.freeradbiomed.2008.08.025. Epub 2008 Sep 9.

47.

Human cerebral neuropathology of Type 2 diabetes mellitus.

Nelson PT, Smith CD, Abner EA, Schmitt FA, Scheff SW, Davis GJ, Keller JN, Jicha GA, Davis D, Wang-Xia W, Hartman A, Katz DG, Markesbery WR.

Biochim Biophys Acta. 2009 May;1792(5):454-69. doi: 10.1016/j.bbadis.2008.08.005. Epub 2008 Aug 22. Review.

48.

The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury.

Anderson KJ, Scheff SW, Miller KM, Roberts KN, Gilmer LK, Yang C, Shaw G.

J Neurotrauma. 2008 Sep;25(9):1079-85. doi: 10.1089/neu.2007.0488.

49.

Dietary choline supplementation improves behavioral, histological, and neurochemical outcomes in a rat model of traumatic brain injury.

Guseva MV, Hopkins DM, Scheff SW, Pauly JR.

J Neurotrauma. 2008 Aug;25(8):975-83. doi: 10.1089/neu.2008.0516.

50.

A time course of contusion-induced oxidative stress and synaptic proteins in cortex in a rat model of TBI.

Ansari MA, Roberts KN, Scheff SW.

J Neurotrauma. 2008 May;25(5):513-26. doi: 10.1089/neu.2007.0451.

PMID:
18533843

Supplemental Content

Loading ...
Support Center